Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC93H109Cl2N11O32 |
InChIKeyKVZUWEFUEGGULL-UHFFFAOYSA-N |
CAS Registry122173-74-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Infections | Preclinical | AR | 01 Feb 1992 |